Chang David D

Allogene Therapeutics, Inc. · President and CEO

Chang David D is listed in public filings as director, officer: President and CEO. This Chang David D insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Allogene Therapeutics, Inc. (ALLO). Investors use Chang David D's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

History Trades

CompanyValueActionPriceCurrent Price
Allogene Therapeutics, Inc.ALLO$171k95.3k sharesSellFeb 2, 2026$1.80--
Allogene Therapeutics, Inc.ALLO$91k46.7k sharesSellMar 14, 2025$1.96--
Allogene Therapeutics, Inc.ALLO$77k46k sharesSellFeb 3, 2025$1.68--